179 related articles for article (PubMed ID: 30381616)
1. Forced Expression of CXCL10 Prevents Liver Metastasis of Colon Carcinoma Cells by the Recruitment of Natural Killer Cells.
Kikuchi N; Ye J; Hirakawa J; Kawashima H
Biol Pharm Bull; 2019 Jan; 42(1):57-65. PubMed ID: 30381616
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
3. CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo.
Wennerberg E; Kremer V; Childs R; Lundqvist A
Cancer Immunol Immunother; 2015 Feb; 64(2):225-35. PubMed ID: 25344904
[TBL] [Abstract][Full Text] [Related]
4. [Effects of hMIP-1beta gene modification on in vivo tumorigenicity and vaccine efficacy of tumor cells].
Luo XL; Xie YA; Kuang ZP; Wu JN; Liang AM
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):97-102. PubMed ID: 18646689
[TBL] [Abstract][Full Text] [Related]
5. Reducing liver metastases of colon cancer in the context of extensive and minor surgeries through β-adrenoceptors blockade and COX2 inhibition.
Sorski L; Melamed R; Matzner P; Lavon H; Shaashua L; Rosenne E; Ben-Eliyahu S
Brain Behav Immun; 2016 Nov; 58():91-98. PubMed ID: 27235931
[TBL] [Abstract][Full Text] [Related]
6. The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.
Meijer J; Zeelenberg IS; Sipos B; Roos E
Cancer Res; 2006 Oct; 66(19):9576-82. PubMed ID: 17018614
[TBL] [Abstract][Full Text] [Related]
7. Prevention of liver metastases through perioperative acute CpG-C immune stimulation.
Sorski L; Melamed R; Levi B; Matzner P; Lavon H; Rosenne E; Shaashua L; Ricon I; Sandbank E; Benbenishty A; Ben-Eliyahu S
Cancer Immunol Immunother; 2020 Oct; 69(10):2021-2031. PubMed ID: 32405793
[TBL] [Abstract][Full Text] [Related]
8. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
9. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
[TBL] [Abstract][Full Text] [Related]
11. Macrophage inflammatory protein-2 promotes angiogenesis, cell migration, and tumor growth in hepatic metastasis.
Kollmar O; Scheuer C; Menger MD; Schilling MK
Ann Surg Oncol; 2006 Feb; 13(2):263-75. PubMed ID: 16424980
[TBL] [Abstract][Full Text] [Related]
12. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice.
Santodomingo-Garzon T; Han J; Le T; Yang Y; Swain MG
Hepatology; 2009 Apr; 49(4):1267-76. PubMed ID: 19140218
[TBL] [Abstract][Full Text] [Related]
13. Effect of Chemokine (C-C Motif) Ligand 7 (CCL7) and Its Receptor (CCR2) Expression on Colorectal Cancer Behaviors.
Kurzejamska E; Sacharczuk M; Landázuri N; Kovtonyuk O; Lazarczyk M; Ananthaseshan S; Gaciong Z; Religa P
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30764543
[TBL] [Abstract][Full Text] [Related]
14. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
Wang P; Yang X; Xu W; Li K; Chu Y; Xiong S
Cancer Immunol Immunother; 2010 Nov; 59(11):1715-26. PubMed ID: 20706716
[TBL] [Abstract][Full Text] [Related]
15. Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor.
Wang XY; Li Y; Manjili MH; Repasky EA; Pardoll DM; Subjeck JR
Cancer Immunol Immunother; 2002 Aug; 51(6):311-9. PubMed ID: 12111119
[TBL] [Abstract][Full Text] [Related]
16. Improved therapeutic effectiveness by combining recombinant CXC chemokine ligand 10 with Cisplatin in solid tumors.
Li G; Tian L; Hou JM; Ding ZY; He QM; Feng P; Wen YJ; Xiao F; Yao B; Zhang R; Peng F; Jiang Y; Luo F; Zhao X; Zhang L; Zhou Q; Wei YQ
Clin Cancer Res; 2005 Jun; 11(11):4217-24. PubMed ID: 15930360
[TBL] [Abstract][Full Text] [Related]
17. Combination of Caspy2 and IP-10 gene therapy significantly improves therapeutic efficacy against murine malignant neoplasm growth and metastasis.
Zhang N; Yang Y; Cheng L; Zhang XM; Zhang S; Wang W; Liu SY; Wang SY; Wang RB; Xu WJ; Dai L; Yan N; Fan P; Dai LX; Tian HW; Liu L; Deng HX
Hum Gene Ther; 2012 Aug; 23(8):837-46. PubMed ID: 22548488
[TBL] [Abstract][Full Text] [Related]
18. EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner.
Bugide S; Gupta R; Green MR; Wajapeyee N
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301901
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
Wang D; Jiang W; Zhu F; Mao X; Agrawal S
Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
[TBL] [Abstract][Full Text] [Related]
20. PARG regulates the proliferation and differentiation of DCs and T cells via PARP/NF‑κB in tumour metastases of colon carcinoma.
Wang JQ; Tang Y; Li QS; Xiao M; Li M; Sheng YT; Yang Y; Wang YL
Oncol Rep; 2019 May; 41(5):2657-2666. PubMed ID: 30864743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
